Sign In

Marc Lemonnier

CEO @ANTABIO, Board member @ BEAM Alliance, SAB member @ JPIAMR

Marc Lemonnier is a prominent figure in the biopharmaceutical industry as the Founding CEO of ANTABIO SAS, a leading private company specializing in the development of innovative treatments for Drug-Resistant Infections caused by critical priority pathogens identified by the World Health Organization (WHO).

He has a notable presence in the fight against AntiMicrobial Resistance in Europe, serving as an Officer at BEAM Alliance, a coalition of biotech companies dedicated to combating antimicrobial resistance.

Additionally, Marc Lemonnier contributes his expertise and insights as a Member of the Scientific Advisory Board of JPIAMR (Joint Programming Initiative on Antimicrobial Resistance), further solidifying his position as a key player in the global efforts to address antimicrobial resistance challenges.

With a background as the Chief Executive Officer at Antabio Sas, Marc Lemonnier brings a wealth of experience and leadership to the field, driving innovative solutions and strategies in the fight against drug-resistant infections.

M
Add to my network

Location

Greater Toulouse Metropolitan Area